KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Dynamics of the EZ/RPE Loss Ratio on OCT Over Time During Geographic Atrophy Progression and Treatment With Pegcetacoplan.

Julia Mai, Gregor S Reiter, Sophie Riedl, Wolf-Dieter Vogl, Amir Sadeghipour, Alex McKeown, Emma Foos, Hrvoje Bogunovic, Ursula Schmidt-Erfurth

Invest Ophthalmol Vis Sci 66(11) 48

PMID40833323
PMCIDPMC12383881
DOI10.1167/iovs.66.11.48
发表日期2025-08-20
入排依据:未发现恶性肿瘤人群证据。
已检查 4 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other。
摘要

摘要

PURPOSE: The purpose of this study was to investigate the change of ellipsoid zone (EZ)/retinal pigment epithelium (RPE) loss ratio on optical coherence tomography (OCT) in geographic atrophy (GA) secondary to age-related macular degeneration using deep learning-based analysis. METHODS: OCT volumes of patients from the OAKS (NCT03525613) and DERBY (NCT03525600) trials, two phase III prospective randomized trials of GA treated with sham, intravitreal pegcetacoplan monthly (PM) and every other month (PEOM) were included. RPE and EZ loss were measured on OCT using validated deep learning-based algorithms. Pooled study eyes were divided into 4 quartiles determined by EZ/RPE loss ratios on OCT at baseline, month 12, and month 24. The change in ratio with treatment and its association with further disease progression and therapeutic response were analyzed. RESULTS: Eight hundred eighty-nine OCT volumes were included. Overall, quartiles shifted downward at 12 and 24 months, representing a moderate decrease in disease activity, particularly in treated eyes. The EZ/RPE loss quartiles at month 12 were prognostic for further disease progression in the sham eyes for RPE and EZ loss. There was a higher likelihood of a quartile decrease in the PM and PEOM groups versus the sham at month 24 (P value quartile shift PM versus sham = 0.14, PEOM versus sham = 0.0053). CONCLUSIONS: The change in EZ/RPE loss ratios at month 12 remained to be predictive for disease activity and therapeutic response, providing insights into disease mechanisms and relevant guidance for GA management in clinical practice. The EZ/RPE loss ratio decreased either due to advanced GA or induced by therapy in treated patients versus sham.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(4,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1Figure 1. Example of a small EZ/RPE loss ratio ( A ), represented by a small EZ loss area outside the area of RPE loss, and a high EZ/RPE loss ratio ( C ), represented by a high EZ loss area outside the area of RPE loss at baseline ( blue = RPE loss, and green = EZ loss). The cases demonstrate a slow progression in growth rates at month 12 in eyes with a small ratio ( B ) and a fast progression in eyes with a high ratio ( D ) at month 12, where RPE loss grows into areas of preexisting EZ loss. EZ, ellipsoid zone; RPE, retinal pigment epithelium.
非 KM Figure
Figure 2Figure 2. Growth of RPE loss between month 12 EZ/RPE loss ratio quartiles in the sham eyes between months 12 and 24. The figure shows the mean change in the area of RPE loss from month 12 to month 24 between the month 12 EZ/RPE loss ratio quartiles in sham eyes, demonstrating a slower progression of RPE loss in smaller ratios and a faster progression in higher ratios. EZ, ellipsoid zone; FOV, field of view; RPE, retinal pigment epithelium; SE, standard error; Q1 to Q4, quartile 1 to quartile 4.
非 KM Figure
Figure 3Figure 3. Growth of EZ loss between month 12 EZ/RPE loss ratio quartiles in the sham eyes between months 12 and 24. The figure shows the mean change in the area of EZ loss from month 12 to month 24 between the month 12 EZ/RPE loss ratio quartiles in sham eyes, demonstrating a slower progression of EZ loss in smaller ratios and a faster progression in higher ratios. EZ, ellipsoid zone; FOV, field of view; RPE, retinal pigment epithelium; SE, standard error; Q1 to Q4, quartile 1 to quartile 4.
非 KM Figure
Figure 4Figure 4. Histogram of EZ/RPE loss ratio change between baseline and month 24 between treatment groups. The histogram shows the percentage of patients that decreased ( red bar ), increased ( grey bar ) or remained in the same ( blue bar ) EZ/RPE loss ratio quartile from baseline to month 24, demonstrating a higher likelihood of a ratio quartile decrease in treated patients versus sham patients. The missing column ( green bar ) contains patients with either missing baseline or month 24 assessment. EZ, ellipsoid zone; PEOM, pegcetacoplan every other month; PM, pegcetacoplan monthly; RPE, retinal pigment epithelium.
非 KM Figure